Physician profile
Christopher Tiu
NPI 1851384408
$3,269.50
in general payments reported to CMS, 2019-2025
11 companies · $180 in 2025
The $180 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $472 · 2022: $361 · 2023: $397 · 2024: $1,860 · 2025: $180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356 · Travel and Lodging: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,355.71 |
| Travel and Lodging | $1,080.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,635.93 | 2022-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $151.56 | 2019 | |
| Alk-Abello, INC | $117.35 | 2019 | |
| Optinose US, INC. | $97.67 | 2019-2022 | |
| Stryker Corporation | $89.97 | 2019 | |
| Genentech USA, INC. | $71.63 | 2022-2025 | Xolair |
| Glaxosmithkline, LLC. | $36.77 | 2022-2023 | Nucala |
| Merck Sharp & Dohme LLC | $23.31 | 2025 | Keytruda |
| Ethicon US, LLC | $16.71 | 2025 | Surgiflo Hemostatic Matrix, Evarrest, Vistaseal |
| Cumberland Pharmaceuticals, INC. | $15.48 | 2019 | |
| Smith+Nephew, INC. | $13.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Tiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.